☰ Sidebar
Voting period for this idea type has passed

SXSW 2018

Healing Healthcare's Reputation

Advances in science have shifted the course of deadly diseases, but have done little to improve the biopharmaceutical industry’s reputation. Poor communication around research and drug pricing have alienated much of society, and the resulting lack of appreciation is seen in public policy. For an industry that innovates and heals, it’s time for change. A veteran journalist leads a discussion with scientists and CEOs who are committed to better public engagement and call their peers to join them.

Share this idea

Related Media


  1. Why does the biopharmaceutical industry have a poor image?
  2. Is this poor image justified?
  3. What can be done to change it?


  • Gene Kinney, President & Chief Executive Officer , Prothena
  • Meg Tirrell, Biotech and Pharma Reporter, CNBC
  • Brent Saunders, Chairman and CEO, Allergan


Sumitra Gupta, Acct Assoc, Canale Communications

Meta Information:

  • Event: SXSW
  • Format: Panel
  • Track: Health & Wellness
  • Level: Beginner
Show me another idea

Add Comments

comments powered by Disqus

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.